Hepatitis B Diagnostic Tests Market
Market Insights on Hepatitis B Diagnostic Tests covering sales outlook, demand forecast & up-to-date key trends
Hepatitis B Diagnostic Tests Market By Product Type (Enzyme Immunoassay Kits, Point-of-Care Testing Kits), End User (Hospitals, Clinics, Diagnostic Centres, Home Care) & Region - Forecast 2017 - 2027
Hepatitis B Diagnostic Tests Market Outlook – 2022-2028
[218 Pages Report] Despite the COVID-19 impact, global Hepatitis B Diagnostic Tests Market experienced a healthy year-on-year (YoY) growth, reaching a valuation of around US$ 872.5 Mn in 2022. With increasing prevalence of hepatitis B worldwide, the overall market is anticipated to register a CAGR of 6.4% between 2022 and 2028, surpassing a valuation of US$ 1.26 Mn by the end of 2028.
Attribute |
Details |
Hepatitis B Diagnostic Tests Market Estimated Size in 2022 |
US$ 872.5 Mn |
Hepatitis B Diagnostic Tests Market value-based CAGR (2022-2028) |
6.4% |
Projected Hepatitis B Diagnostic Tests Market Size in 2028 |
US$ 1.26 Bn |
Enzyme immunoassay (EIA) will continue to remain the most preferred diagnostic test for the detection of hepatitis B, accounting for a massive share of 89.9% in 2022. Various benefits of enzyme immunoassay kits such as reduced assay time, requirement of small sample size, and quick and accurate results.
Regionally Asia Pacific is projected to emerge as the most lucrative market for hepatitis B diagnostic tests, holding around 30.3% share of the global market in 2022. Growth in the region is driven by increasing patient pool and rising government support.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
Particulars |
Details |
H1, 2021 |
6.29% |
H1, 2022 Projected |
6.36% |
H1, 2022 Outlook |
6.16% |
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 20 ↓ |
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 13 ↓ |
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 20 BPS. However, In H1-2022, the market growth rate of hepatitis B diagnostic tests is expected to fall by 13 basis point share (BPS) as compared to H1-2021, as per FMI analysis.
The dip in the BPS values is associated with the limitations of laboratory-based immunoassay techniques, rapid diagnostic tests, and nucleic acid testing technologies. High capital requirements for well-established laboratory facilities and equipment, random-access analysers, or incubators, as well as requirement of trained laboratory technicians, and refrigeration for reagents usage, are some of the factors further inducing a decline in the BPS values.
The global hepatitis B diagnostic tests market is subject to dynamics including regulations, product adoption, disease epidemiology, and technological innovations, as per the industry and macro economical standards. The key development in the market includes the production of rapid test kits for hepatitis B diagnostic tests.
Thus, the emergence of rapid diagnostic kits have provided a mitigative approach towards the cost and technological constraints associated with the above mentioned factors, thus providing propulsion to the market in terms of sales.
2017-2021 Hepatitis B Diagnostic Tests Market Outlook Compared to 2022-2028 Forecast
The hepatitis B diagnostic tests market is set to register a robust CAGR of 6.4% between 2022 and 2028 in comparison to 6.2% CAGR registered from 2017 to 2021.
According to Future Market Insights (FMI), increasing prevalence of hepatitis B, growing government support, advancement in diagnostic technology, higher blood transfusion rates and rising need for early diagnosis of hepatitis B are some of the major factors driving the hepatitis B diagnostic tests market.
Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It has become a major global healthcare concern over the last few decades.
Rising incidence of hepatitis B across the globe is a major factor driving the hepatitis B diagnostic tests market. According to the World Health Organization (WHO), an estimated 296 million people were diagnosed with chronic hepatitis B infection in 2019. Furthermore, around 1.5 million new infections of hepatitis B occur each year.
Early detection of hepatitis B becomes a crucial step in treating the disease as well as in curbing its spread. Hepatitis B is a “silent epidemic” because it does not manifest symptoms in majority of the newly infected or chronically infected people. If it remains undetected in the earlier stages, it can transform from acute to chronic form which is untreatable and fatal. As a result, People are opting for regular diagnostic tests for the detection of hepatitis at earlier stages.
When identified in earlier stages, hepatitis B is more likely to respond to treatment and thus enhance the chances of survival. As per WHO’s study, around 4.5 million premature deaths due to hepatitis can be prevented in low- and middle-income countries by 2030 through diagnostic tests, education campaigns, vaccination and medicines. Increase in diagnostic procedures will continue to boost the sales of hepatitis B diagnostic test kits during the forecast period.
Growing awareness among people about hepatitis B and its consequences is fostering the demand for hepatitis B diagnostic tests. Governments across the world are continuously launching initiatives to educate people about the benefits of hepatitis B diagnostic testing. Huge investments are being made to counter the global burden of hepatitis B.
As hepatitis B spread through body fluids, continuous testing is being highly recommended before blood donations, blood transfusion and during pregnancy. This is boosting the sales of hepatitis B diagnostic solutions.
Moreover, the growing popularity of point of care testing is further accelerating the growth of the market and the trend is likely to continue in the future.
A total valuation of US$ 1.26 Bn has been projected for the global hepatitis B diagnostic tests market by FMI through 2028.
How Will The Government Initiatives Spur Hepatitis B Diagnostic Tests Market Growth?
Rising mortality rate of hepatitis B has compelled government and other international organization to launch various initiatives and programs. Huge funds are being directed towards educating people about the hepatitis B, its prevention and the importance of diagnostic tests.
It has been found that delay in treatment of hepatitis B can lead to serious health issues such as liver cancer, liver cirrhosis and even death. Early diagnosis remains a key aspect for managing the hepatitis B disease.
Various action plans and programs are being launched to promote the adoption of hepatitis B diagnostic testing. For instance, in July 2018 Ministry of Health and Family Welfare, Government of India launched the National Viral Hepatitis Control Program to eliminate hepatitis by 2030 and achieve significant reduction in the infected population, morbidity and mortality associated with hepatitis B and C.
One of the main objectives of the program is to provide early diagnosis and management of viral hepatitis at all levels of healthcare.
In June 2021, WHO launched first-ever global guidance for country validation of viral hepatitis B and C elimination. Similarly, a growing number of hepatitis elimination projects are being established across the United States to promote hepatitis B diagnostic testing.
Furthermore, various voluntary and nonprofit organizations are being formed across the world to educate people about hepatitis B and importance of early diagnosis.
Spurred by these programs, the hepatitis B diagnostic tests market is set to expand 1.45X through 2028.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
What Is Driving The Demand For Hepatitis B Diagnostic Tests In The U.S.?
As per FMI, hepatitis B diagnostic tests market in the U.S. will accelerate at a steady CAGR of 4.3% between 2022 and 2028. Growth in the country is attributed to the rising health awareness, well established healthcare sector, and presence of leading players and increasing prevalence of hepatitis B
Over the years, diagnostic screening for hepatitis B has risen drastically across the U.S. Rising health awareness and involvement of government and other healthcare organizations is boosting the hepatitis B diagnostic tests market in the country.
According to the U.S. Department of Health and Human Services, around 850,000 people in the U.S. are living with hepatitis B. However, the actual number may be as high as 2.2 million or as low as 730,000.
Majority of the persons living with hepatitis B do not know that they have virus. Almost around 67% of persons living with hepatitis B infection in the U.S do not know they have the virus. As a result, early diagnosis is important to prevent the spread and reduce the mortality rate.
What Are The Growth Projections For India Hepatitis B Diagnostic Tests Market?
As per FMI, India is set to register the fastest growth in the hepatitis B diagnostic tests market, growing at a robust CAGR of 7.7% between 2022 and 2028. Expanding healthcare infrastructure, increasing government support, surging diagnostic rates and rising cases of hepatitis B.
Hepatitis B has become a public health problem in India, with a high mortality rate. According to a report by WHO, it is estimated that there are around 40 million people chronically infected with hepatitis B in India.
Various steps are being taken to control the spread of this disease. Hepatitis B generally spread through body fluids; any negligence can lead to serious consequences. Proper diagnosis becomes vital for curbing its spread. As a result, government is providing sufficient testing solutions across hospitals and other healthcare setups to increase the diagnostic rates. This is spurring the growth of hepatitis B diagnostic tests market.
How Will The Growth Unfold In China Hepatitis B Diagnostic Tests Market?
China will continue to remain one of the most lucrative markets for hepatitis B diagnostic tests, expanding at a healthy CAGR of 6.5% over the forecast period. Market in the country is mainly driven by rapidly rising population, increasing prevalence of hepatitis B and increasing diagnostic rates.
According to the WHO, China has the largest burden of hepatitis B cases in the world. There are around 70 million HBV-infected people in China right now. To tackle this burden, vaccination, counselling and early diagnosis will play a crucial role.
The government of China has also launched various initiatives to eradicate this fatal disease by 2030. It works closely with international organizations such as WHO to achieve its goal.
FMI, predicts a market share of 30.3% for Asia Pacific Excluding Japan (APEJ) in 2022, with China leading at the forefront.
Category-wise Insights
Which Product Type Dominates The Hepatitis B Diagnostic Tests Market?
According to FMI’s latest report, the enzyme immunoassay kits will continue to remain the most preferred products for the diagnosis of hepatitis B. A gigantic market share of 89.9% has been predicted for enzyme immunoassay kits segment by FMI.
Enzyme immunoassay (EIA) tests are being extensively employed for the detection of surface antigen (HBsAg) as well as for measurement of antibodies in blood. Enzyme immunoassay tests such as ELISA (enzyme-linked immunosorbent assay) have gained significant traction for the detection of hepatitis B due to their high sensitivity and specificity. These tests are more simpler, accurate and reliable than other diagnostic tests.
Rising adoption of enzyme immunoassay tests for the early detection of hepatitis B will continue to fuel the sales of EIA test kits.
Which Is The Leading End User Of Hepatitis B Diagnostic Tests?
Based on end user, the hepatitis B diagnostic tests market has been segmented into hospitals, clinics, diagnostic centres and home care.
Hospitals segment is anticipated to remain the most lucrative end user for hepatitis B diagnostic tests, growing at a CAGR of around 6.1% between 2022 and 2028.
Rising number of hospitals worldwide and increasing government investments to provide better diagnostic products are boosting the sales of hepatitis B diagnostic testing products. As diagnostic tests are offered free of cost at hospitals, majority of people usually opt for them.

An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competitive Landscape
Leading players operating in the hepatitis B diagnostic tests market are investing vigorously in research activities for the development of low cost and efficient diagnostic tests. Besides this, they are leveraging various growth strategies such as partnerships, acquisitions, collaborations and advanced product launches & approvals to dominate the market.
-
In May 2021, Biosynex SA, a leading designer and distribution of rapid diagnostic tests acquired Avalun SAS to become the European leader in rapid diagnostic testing. The acquisition will help the company to further expand its presence.
-
In December 2021, Roche launched first infectious disease tests on the Cobas 5800 system, a molecular laboratory instrument. The new tests will support patient management of human immunodeficiency virus, hepatitis B and C virus.
In February 2019, Abbott received the CE mark for the world's most sensitive point of care rapid diagnostic test for the detection of hepatitis B.
Scope Of The Report
Attribute |
Details |
Forecast Period |
2017-2022 |
Historical Data Available for |
2022-2028 |
Market Analysis |
Units for Volume and US$ Mn for Value |
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa |
Key Countries Covered |
US, Canada, Mexico, Brazil, Germany, U.K., France, Italy, Spain, Russia, Poland, China, Japan, South Korea, India, ASEAN, Turkey and South Africa |
Key Segments Covered |
Product Type, End-User and Region |
Key Companies Profiled |
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing |
Available upon Request |
Hepatitis B Diagnostic Tests Market By Category
Product Type:
- Enzyme Immunoassay Kits
- Hepatitis B Surface Antigen Test
- Anti-Hepatitis B Surface Antibody Test
- Anti-Hepatitis B Core Antibody Test
- Point-of-Care Testing Kits
- Strips
- Cassettes/Cards
End User:
- Hospitals
- Clinics
- Diagnostic Centres
- Home Care
Region:
- North America
- Western Europe
- Eastern Europe
- Latin America
- Asia-Pacific excluding Japan
- Japan
- Middle East and Africa
Frequently Asked Questions
The hepatitis B diagnostic tests market is estimated to be worth around US$ 872.5 Mn in 2022.
As per FMI, the hepatitis B diagnostic tests market is forecast to register a CAGR of 6.4% between 2022 and 2028.
The hepatitis B diagnostic tests market grew at a CAGR of 6.2% between 2017 and 2022.
Increasing incidence of hepatitis B, continuous testing product approvals and rising adoption of hepatitis B testing during pregnancy and blood transfusion are some of the key trends shaping the market growth.
The North American hepatitis B diagnostic tests market demand is set to account for 19.4% share in 2022.
The hepatitis B diagnostic tests market in Western Europe is projected to account for 17% by 2022.
Bio-Rad Laboratories, Inc., bioMérieux SA, DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience, Inc., Vista Diagnostics International, Biogate Laboratories Ltd., J.Mitra & Co. Ltd., Siemens Medical Solutions USA, Inc. and General Biologicals Corporation. are some of the leading players operating in the hepatitis B diagnostic tests market.
Japan is anticipated to register a CAGR of 4.7% between 2022 and 2028.
Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Hepatitis B Diagnostic Test Market View Point
3.1. Pricing Analysis
3.2. Macro-Economic Factors
3.3. Opportunity Analysis
4. North America Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2022-2028
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2017-2022
4.5.1. Enzyme Immunoassay Kits
4.5.1.1. Hepatitis B surface antigen test
4.5.1.2. Anti-hepatitis B surface antibody test
4.5.1.3. Anti-hepatitis B core antibody test
4.5.2. Point-of-care Testing Kits
4.5.2.1. Strips
4.5.2.2. Cassettes/Cards
4.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2022-2028
4.6.1. Enzyme Immunoassay Kits
4.6.1.1. Hepatitis B surface antigen test
4.6.1.2. Anti-hepatitis B surface antibody test
4.6.1.3. Anti-hepatitis B core antibody test
4.6.2. Point-of-care Testing Kits
4.6.2.1. Strips
4.6.2.2. Cassettes/Cards
4.7. Historical Market Size (US$ Mn) and Analysis By End User, 2017-2022
4.7.1. Hospitals
4.7.2. Clinics
4.7.3. Diagnostic Centers
4.7.4. Home Care
4.8. Market Size (US$ Mn) and Forecast By End User, 2022-2028
4.8.1. Hospitals
4.8.2. Clinics
4.8.3. Diagnostic Centers
4.8.4. Home Care
4.9. Drivers and Restraints: Impact Analysis
4.10. Market Attractiveness Analysis
4.10.1. By Country
4.10.2. By Product Type
4.10.3. By End User
4.11. Key Representative Market Participants
4.12. Key Participants Market Presence (Intensity Map)
5. Western Europe Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
5.3.1. Germany
5.3.2. United Kingdom
5.3.3. France
5.3.4. Italy
5.3.5. Spain
5.3.6. Nordic Region
5.3.7. BENELUX
5.3.8. Rest of Western Europe
5.4. Market Size (US$ Mn) Forecast By Country, 2022-2028
5.4.1. Germany
5.4.2. United Kingdom
5.4.3. France
5.4.4. Italy
5.4.5. Spain
5.4.6. Nordic Region
5.4.7. BENELUX
5.4.8. Rest of Western Europe
5.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2017-2022
5.5.1. Enzyme Immunoassay Kits
5.5.1.1. Hepatitis B surface antigen test
5.5.1.2. Anti-hepatitis B surface antibody test
5.5.1.3. Anti-hepatitis B core antibody test
5.5.2. Point-of-care Testing Kits
5.5.2.1. Strips
5.5.2.2. Cassettes/Cards
5.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2022-2028
5.6.1. Enzyme Immunoassay Kits
5.6.1.1. Hepatitis B surface antigen test
5.6.1.2. Anti-hepatitis B surface antibody test
5.6.1.3. Anti-hepatitis B core antibody test
5.6.2. Point-of-care Testing Kits
5.6.2.1. Strips
5.6.2.2. Cassettes/Cards
5.7. Historical Market Size (US$ Mn) and Analysis By End User, 2017-2022
5.7.1. Hospitals
5.7.2. Clinics
5.7.3. Diagnostic Centers
5.7.4. Home Care
5.8. Market Size (US$ Mn) and Forecast By End User, 2022-2028
5.8.1. Hospitals
5.8.2. Clinics
5.8.3. Diagnostic Centers
5.8.4. Home Care
5.9. Drivers and Restraints: Impact Analysis
5.10. Market Attractiveness Analysis
5.10.1. By Country
5.10.2. By Product Type
5.10.3. By End User
5.11. Key Representative Market Participants
5.12. Key Participants Market Presence (Intensity Map)
6. Eastern Europe Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
6.3.1. Russia
6.3.2. Poland
6.3.3. Rest of Eastern Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2022-2028
6.4.1. Russia
6.4.2. Poland
6.4.3. Rest of Eastern Europe
6.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2017-2022
6.5.1. Enzyme Immunoassay Kits
6.5.1.1. Hepatitis B surface antigen test
6.5.1.2. Anti-hepatitis B surface antibody test
6.5.1.3. Anti-hepatitis B core antibody test
6.5.2. Point-of-care Testing Kits
6.5.2.1. Strips
6.5.2.2. Cassettes/Cards
6.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2022-2028
6.6.1. Enzyme Immunoassay Kits
6.6.1.1. Hepatitis B surface antigen test
6.6.1.2. Anti-hepatitis B surface antibody test
6.6.1.3. Anti-hepatitis B core antibody test
6.6.2. Point-of-care Testing Kits
6.6.2.1. Strips
6.6.2.2. Cassettes/Cards
6.7. Historical Market Size (US$ Mn) and Analysis By End User, 2017-2022
6.7.1. Hospitals
6.7.2. Clinics
6.7.3. Diagnostic Centers
6.7.4. Home Care
6.8. Market Size (US$ Mn) and Forecast By End User, 2022-2028
6.8.1. Hospitals
6.8.2. Clinics
6.8.3. Diagnostic Centers
6.8.4. Home Care
6.9. Drivers and Restraints: Impact Analysis
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Product Type
6.10.3. By End User
6.11. Key Representative Market Participants
6.12. Key Participants Market Presence (Intensity Map)
7. Latin America Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
7.3.1. Brazil
7.3.2. Mexico
7.3.3. Rest of Latin America
7.4. Market Size (US$ Mn) Forecast By Country, 2022-2028
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Rest of Latin America
7.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2017-2022
7.5.1. Enzyme Immunoassay Kits
7.5.1.1. Hepatitis B surface antigen test
7.5.1.2. Anti-hepatitis B surface antibody test
7.5.1.3. Anti-hepatitis B core antibody test
7.5.2. Point-of-care Testing Kits
7.5.2.1. Strips
7.5.2.2. Cassettes/Cards
7.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2022-2028
7.6.1. Enzyme Immunoassay Kits
7.6.1.1. Hepatitis B surface antigen test
7.6.1.2. Anti-hepatitis B surface antibody test
7.6.1.3. Anti-hepatitis B core antibody test
7.6.2. Point-of-care Testing Kits
7.6.2.1. Strips
7.6.2.2. Cassettes/Cards
7.7. Historical Market Size (US$ Mn) and Analysis By End User, 2017-2022
7.7.1. Hospitals
7.7.2. Clinics
7.7.3. Diagnostic Centers
7.7.4. Home Care
7.8. Market Size (US$ Mn) and Forecast By End User, 2022-2028
7.8.1. Hospitals
7.8.2. Clinics
7.8.3. Diagnostic Centers
7.8.4. Home Care
7.9. Drivers and Restraints: Impact Analysis
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Product Type
7.10.3. By End User
7.11. Key Representative Market Participants
7.12. Key Participants Market Presence (Intensity Map)
8. Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) and Analysis By Country, 2017-2022
8.3.1. China
8.3.2. India
8.3.3. Australia and New Zealand
8.3.4. ASEAN
8.3.5. Rest of APEJ
8.4. Market Size (US$ Mn) and Forecast By Country, 2022-2028
8.4.1. China
8.4.2. India
8.4.3. Australia and New Zealand
8.4.4. ASEAN
8.4.5. Rest of APEJ
8.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2017-2022
8.5.1. Enzyme Immunoassay Kits
8.5.1.1. Hepatitis B surface antigen test
8.5.1.2. Anti-hepatitis B surface antibody test
8.5.1.3. Anti-hepatitis B core antibody test
8.5.2. Point-of-care Testing Kits
8.5.2.1. Strips
8.5.2.2. Cassettes/Cards
8.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2022-2028
8.6.1. Enzyme Immunoassay Kits
8.6.1.1. Hepatitis B surface antigen test
8.6.1.2. Anti-hepatitis B surface antibody test
8.6.1.3. Anti-hepatitis B core antibody test
8.6.2. Point-of-care Testing Kits
8.6.2.1. Strips
8.6.2.2. Cassettes/Cards
8.7. Historical Market Size (US$ Mn) and Analysis By End User, 2017-2022
8.7.1. Hospitals
8.7.2. Clinics
8.7.3. Diagnostic Centers
8.7.4. Home Care
8.8. Market Size (US$ Mn) and Forecast By End User, 2022-2028
8.8.1. Hospitals
8.8.2. Clinics
8.8.3. Diagnostic Centers
8.8.4. Home Care
8.9. Drivers and Restraints: Impact Analysis
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By End User
8.11. Key Representative Market Participants
8.12. Key Participants Market Presence (Intensity Map)
9. Japan Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028
9.1. Introduction
9.2. Japan Market Dynamics
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2017-2022
9.3.1. Enzyme Immunoassay Kits
9.3.1.1. Hepatitis B surface antigen test
9.3.1.2. Anti-hepatitis B surface antibody test
9.3.1.3. Anti-hepatitis B core antibody test
9.3.2. Point-of-care Testing Kits
9.3.2.1. Strips
9.3.2.2. Cassettes/Cards
9.4. Market Size (US$ Mn) and Volume Forecast By Product Type, 2022-2028
9.4.1. Enzyme Immunoassay Kits
9.4.1.1. Hepatitis B surface antigen test
9.4.1.2. Anti-hepatitis B surface antibody test
9.4.1.3. Anti-hepatitis B core antibody test
9.4.2. Point-of-care Testing Kits
9.4.2.1. Strips
9.4.2.2. Cassettes/Cards
9.5. Historical Market Size (US$ Mn) and Analysis By End User, 2017-2022
9.5.1. Hospitals
9.5.2. Clinics
9.5.3. Diagnostic Centers
9.5.4. Home Care
9.6. Market Size (US$ Mn) and Forecast By End User, 2022-2028
9.6.1. Hospitals
9.6.2. Clinics
9.6.3. Diagnostic Centers
9.6.4. Home Care
9.7. Drivers and Restraints: Impact Analysis
9.8. Market Attractiveness Analysis
9.8.1. By Product Type
9.8.2. By End User
9.9. Key Representative Market Participants
9.10. Key Participants Market Presence (Intensity Map)
10. Middle East and Africa Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028
10.1. Introduction
10.2. Regional Market Dynamics
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3. Historical Market Size (US$ Mn) and Analysis By Country, 2017-2022
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of Middle East and Africa
10.4. Market Size (US$ Mn) and Forecast By Country, 2022-2028
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of Middle East and Africa
10.5. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2017-2022
10.5.1. Enzyme Immunoassay Kits
10.5.1.1. Hepatitis B surface antigen test
10.5.1.2. Anti-hepatitis B surface antibody test
10.5.1.3. Anti-hepatitis B core antibody test
10.5.2. Point-of-care Testing Kits
10.5.2.1. Strips
10.5.2.2. Cassettes/Cards
10.6. Market Size (US$ Mn) and Volume Forecast By Product Type, 2022-2028
10.6.1. Enzyme Immunoassay Kits
10.6.1.1. Hepatitis B surface antigen test
10.6.1.2. Anti-hepatitis B surface antibody test
10.6.1.3. Anti-hepatitis B core antibody test
10.6.2. Point-of-care Testing Kits
10.6.2.1. Strips
10.6.2.2. Cassettes/Cards
10.7. Historical Market Size (US$ Mn) and Analysis By End User, 2017-2022
10.7.1. Hospitals
10.7.2. Clinics
10.7.3. Diagnostic Centers
10.7.4. Home Care
10.8. Market Size (US$ Mn) and Forecast By End User, 2022-2028
10.8.1. Hospitals
10.8.2. Clinics
10.8.3. Diagnostic Centers
10.8.4. Home Care
10.9. Drivers and Restraints: Impact Analysis
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By End User
10.11. Key Representative Market Participants
10.12. Key Participants Market Presence (Intensity Map)
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
13.1.1. bioMérieux SA
13.1.2. Bio-Rad Laboratories, Inc.
13.1.3. DiaSorin S.p.A.
13.1.4. Abbott Laboratories
13.1.5. Meridian Bioscience, Inc.
13.1.6. Vista Diagnostics International
13.1.7. Biogate Laboratories Ltd.
13.1.8. J.Mitra & Co. Ltd.
13.1.9. Siemens Medical Solutions USA, Inc.
13.1.10. General Biologicals Corporation
14. Global Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028 By Region
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Region
14.2.1. North America
14.2.2. Western Europe
14.2.3. Eastern Europe
14.2.4. Latin America
14.2.5. Asia Pacific Excluding Japan
14.2.6. Japan
14.2.7. Middle East and Africa
14.3. Market Size (US$ Mn) Forecast By Region
14.3.1. North America
14.3.2. Western Europe
14.3.3. Eastern Europe
14.3.4. Latin America
14.3.5. Asia Pacific Excluding Japan
14.3.6. Japan
14.3.7. Middle East and Africa
14.4. Market Attractiveness Analysis By Region
15. Global Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028, By Product Type
15.1. Introduction/Key Finding
15.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2017-2022
15.2.1. Enzyme Immunoassay Kits
15.2.1.1. Hepatitis B surface antigen test
15.2.1.2. Anti-hepatitis B surface antibody test
15.2.1.3. Anti-hepatitis B core antibody test
15.2.2. Point-of-care Testing Kits
15.2.2.1. Strips
15.2.2.2. Cassettes/Cards
15.3. Market Size (US$ Mn) and Volume Forecast By Product Type, 2022-2028
15.3.1. Enzyme Immunoassay Kits
15.3.1.1. Hepatitis B surface antigen test
15.3.1.2. Anti-hepatitis B surface antibody test
15.3.1.3. Anti-hepatitis B core antibody test
15.3.2. Point-of-care Testing Kits
15.3.2.1. Strips
15.3.2.2. Cassettes/Cards
15.4. Market Attractiveness Analysis By Product Type
16. Global Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028, By End User
16.1. Introduction/Key Finding
16.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2022
16.2.1. Hospitals
16.2.2. Clinics
16.2.3. Diagnostic Centers
16.2.4. Home Care
16.3. Market Size (US$ Mn) Forecast By End User, 2022-2028
16.3.1. Hospitals
16.3.2. Clinics
16.3.3. Diagnostic Centers
16.3.4. Home Care
16.4. Market Attractiveness Analysis By End User
17. Global Hepatitis B Diagnostic Test Market Analysis 2017-2022 and Forecast 2022-2028
17.1. Market Size and Y-o-Y Growth
17.2. Absolute $ Opportunity
17.3. Value Chain
18. Assumptions and Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01 : North America Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Country
Table 02 : North America Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Product Type
Table 03 : North America Hepatitis B Diagnostic Test Volume (‘000 tests) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 04 : North America Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By End User
Table 05 : Western Europe Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Country
Table 06 : Western Europe Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Product Type
Table 07 : Western Europe Hepatitis B Diagnostic Test Volume (‘000 tests) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 08 : Western Europe Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By End User
Table 09 : Eastern Europe Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Country
Table 10 : Eastern Europe Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Product Type
Table 11 : Eastern Europe Hepatitis B Diagnostic Test Volume (‘000 tests) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 12 : Eastern Europe Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By End User
Table 13 : Latin America Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Country
Table 14 : Latin America Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Product Type
Table 15 : Latin America Hepatitis B Diagnostic Test Volume (‘000 tests) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 16 : Latin America Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By End User
Table 17 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Country
Table 18 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Product Type
Table 19 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Volume (‘000 tests) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 20 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By End User
Table 21 : Japan Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Product Type
Table 22 : Japan Hepatitis B Diagnostic Test Volume (‘000 tests) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 23 : Japan Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By End User
Table 24 : Middle East & Africa Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Country
Table 25 : Middle East & Africa Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Product Type
Table 26 : Middle East & Africa Hepatitis B Diagnostic Test Volume (‘000 tests) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 27 : Middle East & Africa Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By End User
Table 28 : Global Hepatitis B Diagnostic Test Market Size (US$ Mn) 2012–2016 and Forecast 2022-2028 By Region,
Table 29 : Global Hepatitis B Diagnostic Test Market Size Analysis (US$ Mn) Analysis 2017-2022 and Forecast 2022-2028, By Product Type
Table 30 : Global Hepatitis B Diagnostic Test Volume (‘000 tests) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 31 : Global Hepatitis B Diagnostic Test Market Size (US$ Mn) 2012–2016 and Forecast 2022-2028 By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01 : Global Hepatitis B Diagnostic Test Market Split By Product Type(2017E)
Figure 02 : Global Hepatitis B Diagnostic Test Market Split By End User (2017E)
Figure 03 : Global Hepatitis B Diagnostic Test Market Split By Region (2017E)
Figure 04 : North America Hepatitis B Diagnostic Test Market Split By Product Type (2017E)
Figure 05 : North America Hepatitis B Diagnostic Test Market Split By End User (2017E)
Figure 06 : North America Hepatitis B Diagnostic Test Market Split By Country (2017E)
Figure 07 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 08 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 09 : U.S. Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 10 : U.S. Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 11 : Canada Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 12 : Canada Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 13 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Enzyme Immunoassay Kits, 2017-2022
Figure 14 : North America Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Enzyme Immunoassay Kits, 2022-2028
Figure 15 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 16 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 17 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Hospitals, 2017-2022
Figure 18 : North America Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2022-2028
Figure 19 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 20 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 21 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Diagnostic Centers, 2017-2022
Figure 22 : North America Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Diagnostic Centers, 2022-2028
Figure 23 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 24 : North America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 25 : North America Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Country
Figure 26 : North America Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Product Type
Figure 27 : North America Hepatitis B Diagnostic Test Market Attractiveness Analysis, By End User
Figure 28 : Western Europe Hepatitis B Diagnostic Test Market Split By Product Type (2017E)
Figure 29 : Western Europe Hepatitis B Diagnostic Test Market Split By End User (2017E)
Figure 30 : Western Europe Hepatitis B Diagnostic Test Market Split By Country (2017E)
Figure 31 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 32 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 33 : Germany Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 34 : Germany Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 35 : UK Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 36 : UK Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 37 : France Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 38 : France Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 39 : Italy Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 40 : Italy Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 41 : Spain Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 42 : Spain Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 43 : Nordic Region Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 44 : Nordic Region Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 45 : Benelux Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 46 : Benelux Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 47 : Rest of Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 48 : Rest of Western Europe Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 49 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Enzyme Immunoassay Kits, 2017-2022
Figure 50 : Western Europe Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Enzyme Immunoassay Kits, 2022-2028
Figure 51 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 52 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 53 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Hospitals, 2017-2022
Figure 54 : Western Europe Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2022-2028
Figure 55 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 56 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 57 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Diagnostic Centers, 2017-2022
Figure 58 : Western Europe Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Diagnostic Centers, 2022-2028
Figure 59 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 60 : Western Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 61 : Western Europe Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Country
Figure 62 : Western Europe Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Product Type
Figure 63 : Western Europe Hepatitis B Diagnostic Test Market Attractiveness Analysis, By End User
Figure 64 : Eastern Europe Hepatitis B Diagnostic Test Market Split By Product Type (2017E)
Figure 65 : Eastern Europe Hepatitis B Diagnostic Test Market Split By End User (2017E)
Figure 66 : Eastern Europe Hepatitis B Diagnostic Test Market Split By Country (2017E)
Figure 67 : Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 68 : Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 69 : Russia Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 70 : Russia Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 71 : Poland Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 72 : Poland Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 73 : Rest of Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 74 : Rest of Eastern Europe Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 75 : Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Enzyme Immunoassay Kits, 2017-2022
Figure 76 : Eastern Europe Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Enzyme Immunoassay Kits, 2022-2028
Figure 77 : Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 78 : Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 79 : Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Hospitals, 2017-2022
Figure 80 : Eastern Europe Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2022-2028
Figure 81 : Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 82 : Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 83: Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Diagnostic Centers, 2017-2022
Figure 84 : Eastern Europe Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Diagnostic Centers, 2022-2028
Figure 85 : Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 86 : Eastern Europe Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 87 : Eastern Europe Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Country
Figure 88 : Eastern Europe Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Product Type
Figure 89 : Eastern Europe Hepatitis B Diagnostic Test Market Attractiveness Analysis, By End User
Figure 90 : Latin America Hepatitis B Diagnostic Test Market Split By Product Type (2017E)
Figure 91 : Latin America Hepatitis B Diagnostic Test Market Split By End User (2017E)
Figure 92 : Latin America Hepatitis B Diagnostic Test Market Split By Country (2017E)
Figure 93 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 94 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 95 : Brazil Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 96 : Brazil Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 97 : Mexico Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 98 : Mexico Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 99 : Rest of Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 100 : Rest of Latin America Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 101 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Enzyme Immunoassay Kits, 2017-2022
Figure 102 : Latin America Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Enzyme Immunoassay Kits, 2022-2028
Figure 103 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 104 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 105 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Hospitals, 2017-2022
Figure 106 : Latin America Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2022-2028
Figure 107 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 108 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 109 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Diagnostic Centers, 2017-2022
Figure 110 : Latin America Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Diagnostic Centers, 2022-2028
Figure 111 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 112 : Latin America Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 113 : Latin America Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Country
Figure 114 : Latin America Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Product Type
Figure 115 : Latin America Hepatitis B Diagnostic Test Market Attractiveness Analysis, By End User
Figure 116 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Split By Product Type (2017E)
Figure 117 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Split By End User (2017E)
Figure 117 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 118 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Split By Country (2017E)
Figure 119 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 120 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 121 : China Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 122 : China Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 123 : India Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 124 : India Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 125 : Australia & New Zealand Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 126 : Australia & New Zealand Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 127 : ASEAN Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 128 : ASEAN Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 129 : Rest of Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 130 : Rest of Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 131 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Enzyme Immunoassay Kits, 2017-2022
Figure 132 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Enzyme Immunoassay Kits, 2022-2028
Figure 133 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 134 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 135 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Hospitals, 2017-2022
Figure 136 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2022-2028
Figure 137 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 138 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 139 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Diagnostic Centers, 2017-2022
Figure 140 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Diagnostic Centers, 2022-2028
Figure 141 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 142 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 143 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Country
Figure 144 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Product Type
Figure 145 : Asia Pacific Excluding Japan Hepatitis B Diagnostic Test Market Attractiveness Analysis, By End User
Figure 146 : Japan Hepatitis B Diagnostic Test Market Split By Product Type (2017E)
Figure 147 : Japan Hepatitis B Diagnostic Test Market Split By End User (2017E)
Figure 148 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 149 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 150 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Enzyme Immunoassay Kits, 2017-2022
Figure 151 : Japan Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Enzyme Immunoassay Kits, 2022-2028
Figure 152 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 153 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 154 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Hospitals, 2017-2022
Figure 155 : Japan Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2022-2028
Figure 156 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 157 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 158 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Diagnostic Centers, 2017-2022
Figure 159 : Japan Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Diagnostic Centers, 2022-2028
Figure 160 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 161 : Japan Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 162 : Japan Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Product Type
Figure 163 : Japan Hepatitis B Diagnostic Test Market Attractiveness Analysis, By End User
Figure 164 : Middle East & Africa Hepatitis B Diagnostic Test Market Split By Product Type (2017E)
Figure 165 : Middle East & Africa Hepatitis B Diagnostic Test Market Split By End User (2017E)
Figure 166 : Middle East & Africa Hepatitis B Diagnostic Test Market Split By Country (2017E)
Figure 167 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 168 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 169 : GCC Countries Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 170 : GCC Countries Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 171 : South Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 172 : South Africa Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 173 : Rest of Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis, 2017-2022
Figure 174 : Rest of Middle East & Africa Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 175 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Enzyme Immunoassay Kits, 2017-2022
Figure 176 : Middle East & Africa Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Enzyme Immunoassay Kits, 2022-2028
Figure 178 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Point-of-Care Testing Kits, 2017-2022
Figure 179 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Hospitals, 2017-2022
Figure 180 : Middle East & Africa Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2022-2028
Figure 181 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 182 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Clinics, 2017-2022
Figure 183 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Diagnostic Centers, 2017-2022
Figure 184 : Middle East & Africa Hepatitis B Diagnostic Test Market Value (US$ Mn) & Y-o-Y Growth (%) By Diagnostic Centers, 2022-2028
Figure 185 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 186 : Middle East & Africa Hepatitis B Diagnostic Test Market Size (US$ Mn) Analysis By Home Care, 2017-2022
Figure 187 : Middle East & Africa Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Country
Figure 188 : Middle East & Africa Hepatitis B Diagnostic Test Market Attractiveness Analysis, By Product Type
Figure 189 : Middle East & Africa Hepatitis B Diagnostic Test Market Attractiveness Analysis, By End User
Figure 190 : Global Hepatitis B Diagnostic Test Market Attractiveness Analysis By Region, 2022-2028
Figure 191 : Global Hepatitis B Diagnostic Test Market Attractiveness Analysis By Product Type , 2022-2028
Figure 192 : Global Hepatitis B Diagnostic Test Market Attractiveness Analysis By End User, 2022-2028
Figure 193 : Global Hepatitis B Diagnostic Test Market Value Analysis and Forecast, 2016–2027 (US$ Mn)
Figure 194 : Global Hepatitis B Diagnostic Test Market Value (US$ Mn), 2017-2022
Figure 195 : Global Hepatitis B Diagnostic Test Market Absolute $ Opportunity (US$ Mn), 2016–2027
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports